We are excited to launch our 2020 fall webinar series, Virtually Together: Critical Insights on Critical Issues.
Beginning September 28, and for the remainder of 2020, Zoom in for a series of accredited webinars featuring keynote speakers and panel discussions on topics critical to the evolving realities of pharmacy practice. In each of these engaging sessions, you'll hear from frontline pharmacists and industry experts from across Canada with their perspectives on some of the most pressing issues facing our profession.
Each webinar will last between 1-2 hours and attendees will receive Statements of Attendance and CEUs for participating in the live virtual sessions or watching the recordings, which will be made available after each event. The entire series is accredited for a total of 9.5 CEUs under CCCEP file #: 8002-2020-3103-C-P. Session dates and registration links will be added as they are confirmed.
Date: October 28, 2020
Time: 1:00 - 3:30 PM EDT (150 mins)
Pharmacists have a key role to play as opioid stewards across Canada. The Opioid Evidence Showcase will feature up to 6 mini-sessions highlighting cutting-edge research that demonstrates the value of pharmacist services in opioid stewardship to both patients and the health system. Each 15-minute presentation will be followed by an interactive Q&A with the researchers. The research presented at this session supports CPhA’ s Pharmacists Opioid Stewardship Initiative (POSI), which has a long-term vision of enhancing pharmacy's ability to meet patient and health system needs by enabling harmonized scope of practice in opioid medication management. Planned sessions include a presentation of the newly published naloxone guidelines, an exploration of patient outcomes resulting from pharmacist interventions in opioid management and a timely qualitative analysis of the impacts of pharmacists’ opioid prescribing activities enabled by the current CDSA exemptions.
- List the benefits to patients and the health care system of an expanded and harmonized pharmacist opioid stewardship role
- Describe opportunities where pharmacists can expand their opioid-related patient care activities by leveraging changes to scope and services
- Reflect on how evidence supporting opioid stewardship can be implemented in your own practice
Supported by an unrestricted educational grant from Emergent BioSolutions Inc
Systemic racism and discrimination are ingrained in all aspects of society, including health care, and need to be addressed in order to achieve meaningful change. The profession of pharmacy is no exception, and failure to confront explicit and implicit bias in our profession has implications for us as health care professionals and for the patients we serve. In this session, CPhA will share the results of a recent survey exploring how discrimination and racism has impacted the pharmacy profession. A panel of pharmacy leaders from academic, regulatory, association, corporate/organization and hospital sectors of the pharmacy world will follow to examine the issues raised by the profession and to reflect on potential strategies to combat racism, touching on pharmacy curricula, research and knowledge translation, policy and practice.
- Identify racism and race-based discrimination in the profession
- Describe the impacts of racism or race-based discrimination on professional practice
- Describe potential strategies to combat racism and race-based discrimination within the broader pharmacy sector (e.g., curricula, research, policy and practice)
Pharmacists are Canadians’ most accessible health care providers. This fact has never been more evident that during the COVID-19 pandemic. Community pharmacies remained open and pharmacists continued to provide essential medication management care to patients while other health care providers closed their doors. However, the pandemic has presented community pharmacy with many practice challenges, including procurement of PPE, maintaining continuity of care for patients, managing drug shortages and providing care to a surge of patients seeking help, all while maintaining increased infection control measures. It is essential to incorporate early lessons learned from the COVID-19 pandemic to help pharmacists be better prepared for any future pandemic or wave. This presentation will highlight key strategies and considerations in achieving patient continuity of care, safeguarding medication supply and optimizing workflow to protect staff and patients. While it is impossible to prevent a pandemic from occurring, there is much pharmacists can do to prepare.
- Identify the various roles pharmacists play during a pandemic
- Discuss changes to workflow and practice to protect pharmacy team members and patients
- List challenges to continuity of care and describe solutions to overcoming these barriers
- Identify strategies for preparedness for future pandemics
The COVID-19 pandemic has provided a unique opportunity for Canadian pharmacists to contribute to preventative and public health and has helped lay the groundwork for a broader role for pharmacists as public health stewards. This session will highlight how pharmacists are building on their skills and capacity as immunizers and public health educators to provide COVID-19 testing and vaccine administration, both in Canada and globally. In addition, we’ll touch on other ways pharmacists can support public health, such as combating the opioid crisis though harm reduction efforts, and we’ll explore barriers and facilitators to helping community pharmacists prepare for new horizons in public health.
- Describe 3 key activities pharmacists could take on in a broader public health role
- Identify barriers and facilitators to achieving a broader public health role
- Explain the steps pharmacists need to take to prepare themselves for a broader public health role